ERK1/2 inhibition overcomes resistance to venetoclax in AML by altering mitochondrial metabolism

被引:0
|
作者
Sharma, Priyanka
Ostermann, Lauren
Piya, Sujan
Baran, Natalia
Tyagi, Anudishi
Hindley, Christopher
Dao, Kim-Hien
Sims, Martin
Battula, V. Lokesh
Andreeff, Michael
Borthakur, Gautam
机构
关键词
D O I
10.1158/1538-7445.AM2023-3860
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3860
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Identification of ERK1/2 mutations that confer resistance to MAPK pathway inhibitors
    Goetz, Eva M.
    Ghandi, Mahmoud
    Treacy, Daniel
    Wagle, Nikhil
    Garraway, Levi A.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [42] CHARACTERIZATION OF HUMAN ERK1 AND ERK2 CDNAS - STRUCTURE-FUNCTION ANALYSIS OF HUMAN ERK1
    OWAKI, H
    MAKAR, R
    ROBBINS, D
    BOULTON, TG
    COBB, M
    GEPPERT, T
    FASEB JOURNAL, 1992, 6 (05): : A1983 - A1983
  • [43] Characterization of a novel ERK1/2 inhibitor, which modulates the phosphorylation and catalytic activity of ERK1/2
    Munck, Joanne M.
    Berdini, Valerio
    Bevan, Luke D.
    Braithwaite, Hannah
    Buck, Ildiko M.
    Cassidy, Megan
    Castro, Juan
    Courtin, Aurelie
    Day, James E.
    East, Charlotte
    Fazal, Lynsey
    Graham, Brent
    Griffiths-Jones, Charlotte M.
    Heightman, Tom D.
    Hindley, Chris J.
    Kidane, Birikiti
    Kucia-Tran, Justyna
    Lyons, John F.
    Martins, Vanessa
    Muench, Sandra
    Murray, Chris W.
    Norton, David
    O'Reilly, Marc
    Palmer, Nick
    Pathuri, Puja
    Reader, Mike
    Rees, David C.
    Rich, Sharna J.
    Richardson, Caroline J.
    Saini, Harpreet K.
    Shah, Alpesh
    Stanczuk, Lukas
    Thompson, Neil T.
    Walton, Hugh
    Wilsher, Nicola E.
    Woolford, Alison J.
    Wallis, Nicola G.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [44] Targeting CREB-Binding Protein (CREBBP) Overcomes Resistance to Azacitidine and Venetoclax Therapy in Acute Myeloid Leukemia (AML)
    LeBlanc, Francis
    Bennett, Josh
    Choi, Kwangmin
    Starczynowski, Daniel T.
    BLOOD, 2023, 142
  • [45] Ouabain potentiates the activation of ERK1/2 by carbachol in parotid gland epithelial cells;: inhibition of ERK1/2 reduces Na+-K+-ATPase activity
    Plourde, D
    Soltoff, SP
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2006, 290 (03): : C702 - C710
  • [46] Upregulation of MAPK/MCL-1 Maintaining Mitochondrial Oxidative Phosphorylation Confers Acquired Resistance to BCL-2 Inhibitor Venetoclax in AML
    Zhang, Qi
    Han, Lina
    Shi, Ce
    Pan, Rongqing
    Ma, Man Chun John
    Ryan, Jeremy
    Kurtz, Stephen E.
    Mu, Hong
    Ruvolo, Vivian
    Ma, Helen
    Andreeff, Michael
    Mi, Yingchang
    Tyner, Jeffrey W.
    Leverson, Joel
    Letai, Anthony
    Davis, Richard Eric
    Konopleva, Marina
    BLOOD, 2016, 128 (22)
  • [47] Mots-c Attenuates Myocardial Mitochondrial Damage Through Inhibition Of Ccn1/erk1/2/egr1 Pathway
    Wang, Manda
    Ma, Jiacheng
    Pang, Xiaoli
    Fu, Yu
    Pan, Yanrong
    Yuan, Jinghan
    Li, Shunchang
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2022, 54 (09) : 103 - 103
  • [48] SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism
    Liang, Xing-Jie
    Finkel, Toren
    Shen, Ding-Wu
    Yin, Jun-Jie
    Aszalos, Adorjan
    Gottesman, Michael M.
    MOLECULAR CANCER RESEARCH, 2008, 6 (09) : 1499 - 1506
  • [49] Olverembatinib (HQP1351) in Combination with Lisaftoclax Overcomes Venetoclax Resistance in Preclinical Model of Acute Myeloid Leukemia (AML)
    Xiong, Yan
    Liang, Zhiyan
    Min, Ping
    Wu, Bingxing
    Yu, Huidan
    Yang, Dajun
    Zhai, Yifan
    BLOOD, 2024, 144 : 5777 - 5778
  • [50] Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape
    Martin, Constance J.
    Datta, Abhishek
    Littlefield, Christopher
    Kalra, Ashish
    Chapron, Christopher
    Wawersik, Stefan
    Dagbay, Kevin B.
    Brueckner, Christopher T.
    Nikiforov, Anastasia
    Danehy, Francis T., Jr.
    Streich, Frederick C., Jr.
    Boston, Christopher
    Simpson, Allison
    Jackson, Justin W.
    Lin, Susan
    Danek, Nicole
    Faucette, Ryan R.
    Raman, Pichai
    Capili, Allan D.
    Buckler, Alan
    Carven, Gregory J.
    Schurpf, Thomas
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (536)